Cymbalta for Musculoskeletal Pain
Cymbalta (duloxetine hydrochloride) is a selective serotonin and norepinephrine reuptake inhibitor (SNRI). It is a prescription-only drug approved for the treatment of chronic musculoskeletal pain and chronic low back pain, which can be caused by conditions such as osteoarthritis. Cymbalta was first approved by the U.S. Food and Drug Administration (FDA) in 2004 for major depressive disorder. Subsequently, it was also approved for treatment of anxiety, pain caused by diabetic neuropathy, and pain caused by fibromyalgia before gaining FDA approval for chronic musculoskeletal pain in 2010.
How Should Surgeons Work Up a Patient with Hip Pain Following THA?
Fortunately, pain following THA is a rare. However, over the lifetime of a THA, patients can experience discomfort. Causes of a painful THA are either intrinsic or extrinsic. Intrinsic etiologies originate from the hip joint itself, while extrinsic causes originate from the soft tissues around the hip.
Cephalosporins
Page 2 of 3